Day One Biopharmaceuticals Inc (DAWN)
16.45
-0.63
(-3.69%)
USD |
NASDAQ |
May 08, 10:12
Day One Biopharmaceuticals Total Assets (Quarterly): 326.64M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 326.64M |
| December 31, 2023 | 376.05M |
| September 30, 2023 | 414.18M |
| June 30, 2023 | 450.76M |
| March 31, 2023 | 323.56M |
| December 31, 2022 | 349.06M |
| September 30, 2022 | 381.86M |
| Date | Value |
|---|---|
| June 30, 2022 | 404.05M |
| March 31, 2022 | 267.78M |
| December 31, 2021 | 289.82M |
| September 30, 2021 | 303.78M |
| June 30, 2021 | 316.54M |
| March 31, 2021 | 160.88M |
| December 31, 2020 | 45.66M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
45.66M
Minimum
Dec 2020
450.76M
Maximum
Jun 2023
315.04M
Average
325.10M
Median
Total Assets (Quarterly) Benchmarks
| Revolution Medicines Inc | 2.062B |
| Zentalis Pharmaceuticals Inc | 551.69M |
| Perspective Therapeutics Inc | 97.89M |
| Electromed Inc | 46.96M |
| Xtant Medical Holdings Inc | 92.61M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 29.84M |
| Shareholders Equity (Quarterly) | 296.81M |